Similar Articles
131 Combinations of lenvatinib and immune checkpoint inhibitors plus transarterial chemoembolization, is it the prime time for unresectable hepatocellular carcinoma?
132 Advancing hepatocellular carcinoma treatment with hepatic arterial infusion chemotherapy
133 Current efficacy of hepatic arterial infusion chemotherapy in hepatocellular carcinoma
134 Multi-clustering study on the association between human leukocyte antigen-DP-DQ and hepatitis B virus-related hepatocellular carcinoma and cirrhosis in Viet Nam
135 Angiotensin II administration in severe thrombocytopenia and chronic venous thrombosis: A case report
136 Evaluating microvascular invasion in hepatitis B virus-related hepatocellular carcinoma based on contrast-enhanced computed tomography radiomics and clinicoradiological factors
137 Low level of hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in compensated cirrhotic patients
138 Benefits and drawbacks of radiofrequency ablation via percutaneous or minimally invasive surgery for treating hepatocellular carcinoma
139 Unlocking the diagnostic potential of vascular endothelial growth factor and interleukin-17: Advancing early detection strategies for hepatocellular carcinoma
140 Systemic treatment of hepatocellular carcinoma secondary to non-alcoholic fatty liver disease
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA